BACKGROUND: Acute kidney injury (AKI) occurs frequently in septic patients. Albuminuria may play a role as an early marker of septic AKI. The potential association between de novo dipstick albuminuria (DA) and septic AKI has not been examined. METHODS: We conducted a single-center observational cohort study of 423 critically ill septic patients without chronic kidney disease (CKD) or prior positive DA within 3 months before admission. The association between de novo DA within the first 24 h of presentation and AKI at 72 h was examined. RESULTS: AKI was identified in 268/423 (63%) patients and 20/423 (4.7%) required dialysis. De novo DA was associated with AKI (univariate OR 1.91; 95% CI 1.27-2.86, p = 0.002). The association persisted in a multivariate logistic regression model adjusted for demographics, baseline kidney function, comorbidities, critical illness parameters, and exposure to nephrotoxins (adjusted OR 1.87; 95% CI 1.21-2.89, p = 0.005). The association between de novo DA and AKI was stronger for severe AKI, i.e. Acute Kidney Injury Network (AKIN) stage 3 (adjusted OR 2.99; 95% CI 1.52-5.85, p = 0.001) and AKIN stage 2 (adjusted OR 1.79; 95% CI 1.002-3.21, p = 0.049) but not AKIN stage 1 (adjusted OR 1.41; 95% CI 0.87-2.29, p = 0.16). CONCLUSIONS: De novo DA within the first 24 h of admission was independently associated with severe AKI in critically ill septic patients. Future studies are required to fully elucidate the utility of DA testing in the early detection and stratification of AKI.
BACKGROUND:Acute kidney injury (AKI) occurs frequently in septic patients. Albuminuria may play a role as an early marker of septic AKI. The potential association between de novo dipstick albuminuria (DA) and septic AKI has not been examined. METHODS: We conducted a single-center observational cohort study of 423 critically ill septicpatients without chronic kidney disease (CKD) or prior positive DA within 3 months before admission. The association between de novo DA within the first 24 h of presentation and AKI at 72 h was examined. RESULTS: AKI was identified in 268/423 (63%) patients and 20/423 (4.7%) required dialysis. De novo DA was associated with AKI (univariate OR 1.91; 95% CI 1.27-2.86, p = 0.002). The association persisted in a multivariate logistic regression model adjusted for demographics, baseline kidney function, comorbidities, critical illness parameters, and exposure to nephrotoxins (adjusted OR 1.87; 95% CI 1.21-2.89, p = 0.005). The association between de novo DA and AKI was stronger for severe AKI, i.e. Acute Kidney Injury Network (AKIN) stage 3 (adjusted OR 2.99; 95% CI 1.52-5.85, p = 0.001) and AKIN stage 2 (adjusted OR 1.79; 95% CI 1.002-3.21, p = 0.049) but not AKIN stage 1 (adjusted OR 1.41; 95% CI 0.87-2.29, p = 0.16). CONCLUSIONS: De novo DA within the first 24 h of admission was independently associated with severe AKI in critically ill septicpatients. Future studies are required to fully elucidate the utility of DA testing in the early detection and stratification of AKI.
Authors: Morgan E Grams; Brad C Astor; Lori D Bash; Kunihiro Matsushita; Yaping Wang; Josef Coresh Journal: J Am Soc Nephrol Date: 2010-07-29 Impact factor: 10.121
Authors: Peter A McCullough; Andrew D Shaw; Michael Haase; Josee Bouchard; Sushrut S Waikar; Edward D Siew; Patrick T Murray; Ravindra L Mehta; Claudio Ronco Journal: Contrib Nephrol Date: 2013-05-13 Impact factor: 1.580
Authors: Joseph V Bonventre; David Basile; Kathleen D Liu; Dianne McKay; Bruce A Molitoris; Karl A Nath; Thomas L Nickolas; Mark D Okusa; Paul M Palevsky; Rick Schnellmann; Krystyna Rys-Sikora; Paul L Kimmel; Robert A Star Journal: Clin J Am Soc Nephrol Date: 2013-07-18 Impact factor: 8.237
Authors: Chang Xu; Anthony Chang; Bradley K Hack; Michael T Eadon; Seth L Alper; Patrick N Cunningham Journal: Kidney Int Date: 2013-07-31 Impact factor: 10.612
Authors: L G Forni; M Darmon; M Ostermann; H M Oudemans-van Straaten; V Pettilä; J R Prowle; M Schetz; M Joannidis Journal: Intensive Care Med Date: 2017-05-02 Impact factor: 17.440
Authors: Javier A Neyra; Xilong Li; Federica Mescia; Victor Ortiz-Soriano; Beverley Adams-Huet; Johanne Pastor; Ming-Chang Hu; Robert D Toto; Orson W Moe Journal: Crit Care Explor Date: 2019-06
Authors: Romain Arrestier; Ségolène Gendreau; David Mokrani; Jean-Philippe Bastard; Soraya Fellahi; François Bagate; Paul Masi; Thomas d'Humières; Keyvan Razazi; Guillaume Carteaux; Nicolas De Prost; Vincent Audard; Armand Mekontso-Dessap Journal: J Clin Med Date: 2022-04-05 Impact factor: 4.241